1. Natural killer cells, ageing and cancer

   • Elissaveta Naumova
   • Graham Pawelec
   • Anastasiya Mihaylova

   Editorial 11 March 2016 Pages: 367 - 370

2. Vaccination using melanoma cells treated with p19arf and interferon beta gene transfer in a mouse model: a novel combination for cancer immunotherapy

   • Ruan Felipe Vieira Medrano
   • João Paulo Portela Catani
   • Bryan E. Strauss

   Original Article 18 February 2016 Pages: 371 - 382

   

3. A phase I/IIa clinical trial in stage IV melanoma of an autologous tumor–dendritic cell fusion (dendritoma) vaccine with low dose interleukin-2

   • Julia M. Greene
   • Erika J. Schneble
   • George E. Peoples

   Original Article 19 February 2016 Pages: 383 - 392

   

4. A beneficial tumor microenvironment in oropharyngeal squamous cell carcinoma is characterized by a high T cell and low IL-17⁺ cell frequency

   • Simone Punt
   • Emilie A. C. Dronkers
   • Ekaterina S. Jordanova

   Original Article Open access 22 February 2016 Pages: 393 - 403

   

5. Local delivery of CpG-B and GM-CSF induces concerted activation of effector and regulatory T cells in the human melanoma sentinel lymph node

   • Mari F. C. M. van den Hout
   • Berbel J. R. Sluijter
   • Tanja D. de Gruijl

   Original Article Open access 02 March 2016 Pages: 405 - 415

   

6. Age-related changes in natural killer cell repertoires: impact on NK cell function and immune surveillance

   • Angela R. Manser
   • Markus Uhrberg

   Symposium-in-writing paper 19 August 2015 Pages: 417 - 426

   

7. Killer-cell immunoglobulin-like receptor genes and ligands and their role in hematologic malignancies

   • Viktoria Varbanova
   • Elissaveta Naumova
   • Anastasiya Mihaylova

   Symposium-in-Writing Paper 13 February 2016 Pages: 427 - 440

   

8. CD57 in human natural killer cells and T-lymphocytes

   • Hassen Kared
   • Serena Martelli
   • Anis Larbi

   Symposium-in-Writing Paper 05 February 2016 Pages: 441 - 452

   

9. Natural killer cell immunosenescence in acute myeloid leukaemia patients: new targets for immunotherapeutic strategies?

   • Beatriz Sanchez-Correa
   • Carmen Campos
   • Raquel Tarazona

   Symposium-in-writing paper 10 June 2015 Pages: 453 - 463

   

10. Human natural killer cells: news in the therapy of solid tumors and high-risk leukemias

    • Gabriella Pietra
    • Chiara Vitale
    • Lorenzo Moretta

    Symposium-in-writing paper 20 August 2015 Pages: 465 - 476

    

11. Selection and expansion of natural killer cells for NK cell-based immunotherapy

    • Petra S. A. Becker
    • Garnet Suck
    • Christian Seidl

    Symposium-in-writing paper Open access 25 January 2016 Pages: 477 - 484

    

12. NK-92: an ‘off-the-shelf therapeutic’ for adoptive natural killer cell-based cancer immunotherapy

    • Garnet Suck
    • Marcus Odendahl
    • Torsten Tonn

    Symposium-in-writing paper 11 November 2015 Pages: 485 - 492